Exane Derivatives’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,500
Closed -$4.5K 705
2020
Q1
$4.5K Hold
1,500
﹤0.01% 459
2019
Q4
$248K Sell
1,500
-1
-0.1% -$43 0.05% 228
2019
Q3
$12 Buy
+1,501
New +$62K ﹤0.01% 650

Other funds holding EEM

Exane Derivatives's EEM Position: Q2 2022 in Review

Exane Derivatives reduced its iShares MSCI Emerging Markets ETF (EEM) stake by 100% in Q2 2022, selling an estimated $712K and leaving 1 share worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Exane Derivatives first reported a position in EEM in Q1 2015 and has held it in 24 quarters since. The position peaked at $31.1M in Q4 2016. 1,283 funds tracked by Wall St. Rank hold EEM as of Q2 2022.

  • Exane Derivatives held 1 share of iShares MSCI Emerging Markets ETF worth $40 as of Q2 2022.
  • Exane Derivatives sold 16,964 iShares MSCI Emerging Markets ETF shares in Q2 2022, an estimated $712K.
  • iShares MSCI Emerging Markets ETF made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #747 holding.
  • Exane Derivatives first reported a position in iShares MSCI Emerging Markets ETF in Q1 2015 and has held it in 24 quarters since.
  • Exane Derivatives's iShares MSCI Emerging Markets ETF position peaked at $31.1M in Q4 2016.
  • 1,283 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.